Crossmark

A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus

Published Online: 2014-04-23

Authors

Liu, Xuebin

Zheng, Pei

Wang, Xiaodong

Dai, Guanghui

Cheng, Hongbin

Zhang, Zan

Hua, Rongrong

Niu, Xinxin

Shi, Jing

An, Yihua
License Information

Text and Data Mining valid from 2014-04-23

Version of Record valid from 2014-04-23
More Information

Article History

Received: 2 June 2013

Revised: 10 November 2013

Accepted: 15 April 2014

First Online: 23 April 2014

Document is current